For more general information, see ovarian cancer. Research suggests that in the first line treatment of Endometrial Ovarian Cancer (EOC), Pegylated Liposomal Doxorubicin paired with Carboplatin is a satisfactory alternative to Paclitaxel with Carboplatin. In people with platinum-sensitive relapsed EOC, research has found that Pegylated Liposomal Doxorubicin with Carboplatin is a better treatment than Paclitaxel with Carboplatin. For advanced cancer of this histology, the US National Cancer Institute recommends a method of chemotherapy that combines intravenous (IV) and intraperitoneal (IP) administration. Preferred chemotherapeutic agents include a platinum drug with a taxane.
Surface epithelial-stromal tumor
Germ cell neoplasia in situ
Keratin implantation cyst
Stromal tumor
Leiomyomatous hamartoma
Neural fibrolipoma
Mammary-type myofibroblastoma
Sclerosing polycystic adenosis